Free introductory signal review for a selected therapy area, giving brand teams a first look at the type of patient intelligence KEEP produces before full enrollment begins.
Example promotion
This is an example of a promotion that could suit this business. It is not a guaranteed active offer or a working discount code. Check the website for current deals.
To the shop
KEEP Labs Inc. is a patient intelligence platform that captures continuous, real-time data from patients living with rare and specialty diseases in their home environment. The platform is designed to give pharmaceutical companies insight into what patients are actually experiencing, not what surveys or claims data reconstruct after the fact.
Your review = Donation to charity + chance on €250
Two minutes of your time. One donation to a good cause, plus a monthly cash raffle.
Photo reviews
No glossy product shots, but what customers actually receive at home.
Impact via KEEP Labs Inc.
You write a review, we donate to a good cause on your behalf.
No donations have been made for KEEP Labs Inc. yet, but every review sets one in motion right away.
Is KEEP Labs Inc. your business? Claim this page for free →
About KEEP Labs Inc.
Primary audience
Pharmaceutical brand teams and agency partners
Therapy areas covered
20+
Patients mapped
4M+ across rare and specialty disease
Weekly active use
85%+ of enrolled patients
Patient conversations
50K+ and growing daily
Enrollment speed
Days, not months
Core technology
Conversational AI (Kai) and passive in-home behavioral monitoring
Data approach
Consent-based, continuous, real-time
KEEP Labs Inc. operates at the intersection of health technology and pharmaceutical commercial strategy, serving brand teams and agency partners in the life sciences sector. The company positions itself not as a traditional research or data vendor but as a continuous presence in the patient home, built around a conversational AI tool and passive in-home behavioral monitoring. Its philosophy rests on the idea that patient trust must be earned before intelligence becomes meaningful, keeping the relationship between KEEP and the patient structurally separate from brand-side access. The platform targets pharmaceutical companies working in rare and specialty disease areas, with more than 20 therapy areas already represented across a network of over four million patients.
Active promotions
Ready to use with your order at KEEP Labs Inc..
Pilot enrollment at no setup cost for qualifying pharmaceutical companies, covering the initial onboarding and first month of continuous patient signal collection.
Example promotion
This is an example of a promotion that could suit this business. It is not a guaranteed active offer or a working discount code. Check the website for current deals.
To the shop
KEEP Labs Inc. in the news
Recent updates and background about KEEP Labs Inc., summarised in our own words.
QDEL stock records notable gain over three-month period
Shares of QDEL have risen by 31.7% over the past three months. Whether this upward trend can be sustained remains an open question for investors and market observers.
Weekly market recap covering ZEUS results and BIOA analyst ratings
A weekly financial summary covers a disappointing performance from ZEUS, which has had implications for BGE-102, alongside updates from analysts who have reduced price targets for BIOA while maintaining a buy recommendation. The recap highlights notable movements in biotech and related sectors.
AI laboratories face challenges in retaining top talent
Artificial intelligence research organizations are increasingly struggling to hold on to their most skilled professionals. Staff departures have become a recurring issue across the sector.
Summaries by Image Review based on publicly available sources and our own editing. External links may contain affiliate links.
What others ask about KEEP Labs Inc.
Answers to the most common questions, based on search behaviour and our own research.
Is KEEP Labs Inc. a trustworthy company?
KEEP Labs Inc. is built around patient consent and trust as core operating principles, and its founders include experienced figures from health tech, clinical pharmacy, and regulated software environments. The platform is designed so that patient data is never used to serve the brand at the patient's expense, which the company describes as the foundation of the intelligence it provides.
What kind of companies use KEEP Labs?
KEEP Labs serves pharmaceutical companies and their commercial agency partners, particularly those working in rare and specialty disease categories. The platform is intended for brand teams who need real-time patient insight rather than retrospective survey or claims data.
How quickly can a pharma company get started with KEEP?
According to KEEP Labs, enrollment into an existing therapy area network can begin within days, with no recruitment lag or build time required.
How does KEEP Labs collect patient data?
Patient data is collected through two layers: a conversational AI health coach called Kai, which captures language shifts and emotional tone over time, and passive in-home behavioral monitoring that sits alongside medication in the home. All data collection is consent-based.
Your turn
Do you have experience with KEEP Labs Inc.?
Help other consumers by sharing your experience, with a photo of what you actually received. It takes two minutes and you automatically join the monthly draw.
€250
cash per month
One winner from all review submitters, drawn on the 1st of the month.
Your review = real impact + chance to win €250
Guarantee: every review triggers one of these 5 real donations:
- 1 Upload a photo Of your order or the product
- 2 Give stars 1 to 5 per aspect
- 3 Trigger a donation Plus a chance at € 250 cash per month
Write a review
Share your photo review about KEEP Labs Inc.
A photo says more than a thousand words. Help other consumers with an honest experience and join the monthly draw for € 250 cash.
- Reviewing anonymously is fine, we only need your email
- No mandatory account, no registration
- Reviews appear after a check within 24 hours
- Monthly chance to win € 250 cash
